IP Library Granted Patent US 10,028,994
Granted Patent B2
US 10,028,994 · App. 15/487,566 · Granted Jul 24, 2018

Memory or learning improvement using peptide and other compositions

Inventor: Nicholas V. Perricone (Madison, CT)
Assignee: Transdermal Biotechnology, Inc.
A61K38/066A61K9/0014A61K33/00A61K38/11A61K38/34A61K9/127A61K9/1274A61K47/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,994
App. No.
15/487,566
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention generally relates to compositions and methods for topical or transdermal delivery, including treatment and prevention of learning and memory disorders, and enhancement of learning or memory. In some cases, the composition may include nitric oxide, peptides, or both. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide and/or peptide. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.

Claims (22)

1. A method, comprising:

administering, to the skin of a subject to improve the subject's memory or learning, a composition comprising an effective amount of a peptide and molecular nitric oxide to improve the subject's memory or learning, and a carrier comprising lecithin complexed to the molecular nitric oxide by hydrogen bonds or van der Waals forces.

2. The method of claim 1 , wherein the peptide comprises thyrotropin-releasing hormone (TRH).

3. The method of claim 1 , wherein the peptide comprises melanocyte-stimulating hormone (MSH).

4. The method of claim 1 , wherein the peptide comprises vasopressin.

5. The method of claim 1 , wherein the carrier further comprises polyenylphosphatidylcholine.

6. The method of claim 1 , wherein the composition comprises a liquid crystal structure.

7. The method of claim 1 , wherein the composition comprises no more than about 250 ppm of water by weight of the composition.

8. The method of claim 1 , wherein the lecithin is present at at least about 0.25% by weight of the composition.

9. The method of claim 1 , wherein the molecular nitric oxide is present at at least about 0.5% by weight of the composition without nitric oxide.

10. The method of claim 1 , wherein the composition is a cream.

11. A method, comprising:

administering, to the skin of a subject to improve the subject's memory or learning, a composition comprising an effective amount of a peptide and molecular nitric oxide to improve the subject's memory or learning, and a carrier comprising lecithin complexed to the molecular nitric oxide by hydrogen bonds or van der Waals forces, wherein the first phase comprises no more than about 250 ppm of water by weight of the composition.

12. The method of claim 11 , wherein the peptide comprises thyrotropin-releasing hormone (TRH).

13. The method of claim 11 , wherein the peptide comprises melanocyte-stimulating hormone (MSH).

14. The method of claim 11 , wherein the peptide comprises vasopressin.

15. The method of claim 11 , wherein the carrier further comprises polyenylphosphatidylcholine.

16. The method of claim 11 , wherein the composition comprises a liquid crystal structure.

17. The method of claim 11 , wherein the composition is stable at room temperature.

18. The method of claim 11 , wherein the lecithin is present at at least about 0.25% by weight of the composition.

19. The method of claim 11 , wherein the molecular nitric oxide is present at at least about 0.5% by weight of the composition without nitric oxide.

20. The method of claim 11 , wherein the composition is a cream.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2017
From: PERRICONE, NICHOLAS V.
To: TRANSDERMAL BIOTECHNOLOGY, INC.
Reel/Frame 042009/0995 →
Continuity (3)
Continuation 13801298 · Mar 13, 2013
Related Publication 20170281715A1 · Oct 5, 2017
Related Publication 20180092959A9 · Apr 5, 2018
Cited By (1)
US 12,268,699